drugset / Trial / NCT00655928

Modulation of Lung Injury Complicating Lung Resection

NCT00655928 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether N-acetylcysteine given intravenously 1 day pre-operatively is effective in preventing inflammation in the lungs, as measured by tests on blood, breath and lung specimens, in patients undergoing surgery to remove a portion of lung.

Timeline

Start
2007-08
Primary completion
2009-07
Completion
2009-07

Outcome

Missed primary endpoint

registry analysis (superiority test); N-acetylcysteine vs Placebo; p = 0.09; t-test, 2 sided NCT00655928 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 240 mg/kg Intravenous

Indications